LaSalle St. Investment Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

LaSalle St. Investment Advisors’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$227K	Hold	1,130	–	–	0.03%	369
2025 Q4	$233K	Buy	+1,130	New	+$226K	0.04%	323

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

LaSalle St. Investment Advisors's FBT Position: Q1 2026 in Review

LaSalle St. Investment Advisors held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q1 2026 at 1,130 shares worth $227K. The position accounts for 0.03% of the portfolio, ranked #369.

LaSalle St. Investment Advisors first reported a position in FBT in Q4 2025 and has held it in 2 quarters since. The position peaked at $233K in Q4 2025. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

LaSalle St. Investment Advisors held 1,130 shares of First Trust NYSE Arca Biotechnology Index Fund worth $227K as of Q1 2026.
LaSalle St. Investment Advisors left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q1 2026.
First Trust NYSE Arca Biotechnology Index Fund made up 0.03% of LaSalle St. Investment Advisors's portfolio in Q1 2026, its #369 holding.
LaSalle St. Investment Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2025 and has held it in 2 quarters since.
LaSalle St. Investment Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $233K in Q4 2025.
307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on LaSalle St. Investment Advisors's 13F filing for Q1 2026, filed 8 May 2026.